GENEVA, July 31 -- ASCLETIS PHARMA (CHINA) CO., LIMITED filed a patent application (CN2026/073425) for “INJECTION OF GLP-1R AGONIST AND PREPARATION METHOD THEREFOR”. With publication no. WO/2026/158226, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/437
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....